NCT02066181 2023-06-07Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive FibromatosisNational Cancer Institute (NCI)Phase 3 Completed87 enrolled 14 charts
NCT05561036 2022-09-30A Randomized, Double-blind,Phase â…¢ Study of Liposome Doxorubicin in Desmoid TumorSun Yat-sen UniversityPhase 3 Unknown72 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts